Clinical significance of homologous recombination deficiency score testing in endometrial Cancer-Reference-Cited by-同舟云学术

Clinical significance of homologous recombination deficiency score testing in endometrial Cancer

Published:2021-03 Issue:3 Volume:160 Page:777-785
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Siedel Jean H.,Ring Kari L.,Hu Wei,Dood Robert L.,Wang Ying,Baggerly Keith,Darcy Kathleen M.,Conrads Thomas P.,Gallagher Shannon,Tshiaba Placede,Neff Chris,Timms Kirsten M.,Mangala Selanere,Westin Shannon N.,Broaddus Russell,Lopez-Berestein Gabriel,Lu Karen H.,Coleman Robert L.,Maxwell George L.,Sood Anil K.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference22 articles.

1. Integrated genomic characterization of endometrial carcinoma;Cancer Genome Atlas Research N;Nature,2013

2. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers;Mutter;J. Natl. Cancer Inst.,2000

3. PTEN in DNA damage repair;Ming;Cancer Lett.,2012

4. ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors;Shen;Cancer Discov.,2015

5. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer;Abkevich;Br. J. Cancer,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced endometrial cancer—The next generation of treatment: A society of gynecologic oncology journal club clinical commentary;Gynecologic Oncology Reports;2024-10

2. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

3. Multiomics analysis of homologous recombination deficiency across cancer types;Biomolecules and Biomedicine;2024-07-28

4. Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms;Molecular Therapy - Nucleic Acids;2024-06

5. Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers;Clinical Cancer Research;2024-03-27